Type d'article
Etat
Reliure
Particularités
Pays
Evaluation du vendeur
Edité par Springer, 2012
ISBN 10 : 1441995293ISBN 13 : 9781441995292
Vendeur : booksXpress, Bayonne, NJ, Etats-Unis
Livre
Hardcover. Etat : new.
Edité par Springer, 2012
ISBN 10 : 1441995293ISBN 13 : 9781441995292
Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis
Livre
Etat : New.
Edité par Springer New York, 2012
ISBN 10 : 1441995293ISBN 13 : 9781441995292
Vendeur : moluna, Greven, Allemagne
Livre impression à la demande
Gebunden. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Sets a basis for effective translational research Emphasis is placed on target identification and drug development using state-of-the-art in vitro and in vivo assaysEach chapter specifically addresses one or more components of preclinical s.
Edité par Springer New York Mrz 2012, 2012
ISBN 10 : 1441995293ISBN 13 : 9781441995292
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Livre impression à la demande
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The purpose of the volume will be to set a basis for effective translational research. By inviting experts in the field of translational stroke research, each chapter will specifically address one or more components of preclinical stroke research. The emphasis will be placed on target identification and drug development using state-of-the-art in vitro and in vivo assays, in combination with in vitro toxicology assays, AMDE and clinical design. 948 pp. Englisch.
Edité par Springer, 2012
ISBN 10 : 1441995293ISBN 13 : 9781441995292
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Livre impression à la demande
Etat : New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Edité par Springer New York, 2012
ISBN 10 : 1441995293ISBN 13 : 9781441995292
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Livre
Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - The purpose of the volume will be to set a basis for effective translational research. By inviting experts in the field of translational stroke research, each chapter will specifically address one or more components of preclinical stroke research. The emphasis will be placed on target identification and drug development using state-of-the-art in vitro and in vivo assays, in combination with in vitro toxicology assays, AMDE and clinical design.